Learn from Invetech’s experts on the new Korus system! Watch this webinar to learn how Korus uses a gentle elutriation process to give you a cleaner cell population to begin cell therapy production processes such as CAR-T, dendritic cell, tumor-infiltrated lymphocytes (TIL), or IPSC-derived.

Discussion topics include:

  • How incorporating lymphocyte elutriation into your T cell therapy manufacturing process can consistently improve your overall cell yield by up to 2.5X compared to a standard wash process
  • The effects of using cleaner lymphocyte populations produced by the Korus on downstream manufacturing operations such as cell selection and expansion
  • Early unpublished data on our monocyte elutriation protocol

Would you like to learn more about the new Korus system?

Learn how Korus can help you start your manufacturing process with cleaner lymphocyte or monocyte populations! Connect with an Invetech team member now!

The Korus system is for research, laboratory or further manufacturing use only. It is not intended as a medical device in therapeutic or diagnostic procedures. Customers are responsible for validating the use of Korus within their process or therapy. Consult all instructions, terms and warnings prior to use of the solutions and products. Failure to do so can result in damage or serious injury, including death. Ready-to-run turnkey systems may require minor configuration before sale and use depending on customer needs.